Talimogene laherparepvec (T-VEC) is an oncolytic virus for melanoma which encodes GM-CSF and sipuleucel-T, an autologous DC infusion for prostate cancer, stimulated ex vivo with a tumour-associated antigen fused to GM-CSF [207,208]. This evidence concerns the gene CSF2 and prostate carcinoma.